ACM
SOPH icon

Archon Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Archon Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99M Buy
691,413
+250,000
+57% +$1.27M 1.62% 22
2026
Q1 		$2.18M Hold
441,413
– – 1.23% 31
2025
Q4 		$2.06M Buy
441,413
+14,342
+3% +$65K 1.17% 28
2025
Q3 		$2.03M Buy
427,071
+105,544
+33% +$363K 1.21% 31
2025
Q2 		$997K Buy
+321,527
New +$959K 0.82% 35

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Archon Capital Management's SOPH Position: Q2 2026 in Review

Archon Capital Management increased its SOPHiA GENETICS (SOPH) stake by 57% in Q2 2026, buying an estimated $1.27M and bringing the position to 691,413 shares worth $3.99M. The position accounts for 1.62% of the portfolio, ranked #22.

Archon Capital Management first reported a position in SOPH in Q2 2025 and has held it in 5 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Archon Capital Management held 691,413 shares of SOPHiA GENETICS worth $3.99M as of Q2 2026.
  • Archon Capital Management bought 250,000 SOPHiA GENETICS shares in Q2 2026, an estimated $1.27M.
  • SOPHiA GENETICS made up 1.62% of Archon Capital Management's portfolio in Q2 2026, its #22 holding.
  • Archon Capital Management first reported a position in SOPHiA GENETICS in Q2 2025 and has held it in 5 quarters since.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Archon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.